|
ORF cDNA clones
|
CRISPR / TALEN
|
Lentivirus
|
AAV
|
TALE-TF
|
ORF knockin clones
|
|
Antibody
|
Proteins
|
miRNA target clones
|
qPCR primers
|
shRNA clones
|
miRNA products
|
Promoter clones
|
Validated All-in-One™ qPCR Primer for AMER1(NM_152424.3) Search again
Product ID:
HQP002961
(click here to view gene annotation page)
Species:
Human
Symbol:
Alias:
FAM123B, OSCS, WTX
Gene Description:
APC membrane recruitment protein 1
Target Gene Accession:
NM_152424.3(click here to view gene page)
Estimated Delivery:
Approximately 1-3 weeks, but may vary. Please email sales@genecopoeia.com or call 301-762-0888 to confirm ETA.
Important Note:
By default, qPCR primer pairs are designed to measure the expression level of the splice variant (accession number) you selected for this gene WITHOUT consideration of other possible variants of this gene. If this gene has multiple variants, and you would like to measure the expression levels of one particular variant, multiple variants, or all variants, please contact us for a custom service project at inquiry@genecopoeia.com.
Validated result:
Gene References into function
- WTX, is inactivated in approximately one-third of Wilms tumors; it is inactivated by a monoallelic "single-hit" event targeting the single X chromosome in tumors from males and the active X chromosome in tumors from females
- findings show that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 and APC; data provide a possible mechanistic explanation for the tumor suppressor activity of WTX
- Deletion of the WTX gene is associated with Wilms' tumor with a balanced translocation t(X;18)
- Gene has a tumor suppressor function in Wilms tumors, and is involved in beta-catenin destruction.
- WT1 and WTX mutations occur with similar frequency, that they partially overlap in Wilms tumors, and that mutations in WT1, WTX, and CTNNB1 underlie the genetic basis of about one-third of Wilms tumors
- Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
- there was not any evidence of WTX mutation in the 143 acute leukemia patients
- WTX is rarely mutated in acute myeloid leukemia
- The observed phenotypic discordance dependent upon whether a mutation is germline or occurs somatically suggests the existence of temporal or spatial constraints on the action of WTX during tumorigenesis.
- Mutations in WTX gene is associated with Wilms tumor.
